darzalex-conc-for-soln-for-iv-infusion-400-mg-20-ml
Darzalex conc for soln for IV infusion 400 mg/20 mL (400 mg/20 mL)
Manufacturer:
Johnson & Johnson
Contents:
daratumumab
MIMS Class:
Targeted Cancer Therapy
Form:
Vial
Shape:
Undefined
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement